Anti-FXYD4/ CHIF monoclonal antibody

Anti-FXYD4/ CHIF antibody for FACS & in-vivo assay

Target products collectionGo to FXYD4/FXYD4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0457-Ab-1/ GM-Tg-hg-MP0457-Ab-2Anti-Human FXYD4 monoclonal antibodyHuman
GM-Tg-rg-MP0457-Ab-1/ GM-Tg-rg-MP0457-Ab-2Anti-Rat FXYD4 monoclonal antibodyRat
GM-Tg-mg-MP0457-Ab-1/ GM-Tg-mg-MP0457-Ab-2Anti-Mouse FXYD4 monoclonal antibodyMouse
GM-Tg-cynog-MP0457-Ab-1/ GM-Tg-cynog-MP0457-Ab-2Anti-Cynomolgus/ Rhesus macaque FXYD4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0457-Ab-1/ GM-Tg-felg-MP0457-Ab-2Anti-Feline FXYD4 monoclonal antibodyFeline
GM-Tg-cang-MP0457-Ab-1/ GM-Tg-cang-MP0457-Ab-2Anti-Canine FXYD4 monoclonal antibodyCanine
GM-Tg-bovg-MP0457-Ab-1/ GM-Tg-bovg-MP0457-Ab-2Anti-Bovine FXYD4 monoclonal antibodyBovine
GM-Tg-equg-MP0457-Ab-1/ GM-Tg-equg-MP0457-Ab-2Anti-Equine FXYD4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0457-Ab-1/ GM-Tg-hg-MP0457-Ab-2; GM-Tg-rg-MP0457-Ab-1/ GM-Tg-rg-MP0457-Ab-2;
GM-Tg-mg-MP0457-Ab-1/ GM-Tg-mg-MP0457-Ab-2; GM-Tg-cynog-MP0457-Ab-1/ GM-Tg-cynog-MP0457-Ab-2;
GM-Tg-felg-MP0457-Ab-1/ GM-Tg-felg-MP0457-Ab-2; GM-Tg-cang-MP0457-Ab-1/ GM-Tg-cang-MP0457-Ab-2;
GM-Tg-bovg-MP0457-Ab-1/ GM-Tg-bovg-MP0457-Ab-2; GM-Tg-equg-MP0457-Ab-1/ GM-Tg-equg-MP0457-Ab-2
Products NameAnti-FXYD4 monoclonal antibody
Formatmab
Target NameFXYD4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FXYD4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FXYD4/ CHIF VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0457
    Target NameFXYD4
    Gene ID53828,108017,64190,107000109,102156028,109492905,100295639,100629797
    Gene Symbol and Synonyms0610008I02Rik,CHIF,FXYD4
    Uniprot AccessionP59646,Q63113
    Uniprot Entry NameFXYD4_HUMAN,FXYD4_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000150201
    Target ClassificationN/A

    The target: FXYD4, gene name: FXYD4, also named as CHIF. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. FXYD4, originally named CHIF for channel-inducing factor, has been shown to modulate the properties of the Na,K-ATPase, as has FXYD2, also known as the gamma subunit of the Na,K-ATPase, and FXYD7. Transmembrane topology has been established for FXYD4 and two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. Alternatively spliced transcript variants encoding the same protein have been found.[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.